Clinical Report: Genetic Markers Linked to Cervical Intervertebral Disc Degeneration

Overview

This study identifies CDKN3, SLC22A4, and SYDE1 as potential diagnostic biomarkers for early-stage cervical intervertebral disc degeneration (IDD).

Background

Cervical intervertebral disc degeneration (IDD) is a significant contributor to neck pain, affecting a large portion of the population. This study explores the genetic markers associated with IDD.

Data Highlights

Key Findings

• A total of 71 differentially expressed genes (DEGs) were identified in IDD samples.
• KEGG pathway analysis showed significant enrichment in inflammation-related pathways.
• CDKN3, SLC22A4, and SYDE1 were identified as key biomarkers for IDD.
• Immune infiltration analysis indicated a relationship between these genes and immune cell populations in IDD.
• qPCR validation confirmed significant expression changes of the identified biomarkers in cervical IDD specimens.

Clinical Implications

The identification of CDKN3, SLC22A4, and SYDE1 as biomarkers may facilitate diagnosis of cervical IDD.

Conclusion

The study presents novel genetic markers associated with cervical IDD. Further research is needed to validate these findings.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Single-cell extracellular vesicle-program scoring maps immunometabolic rewiring and immune crosstalk of mesenchymal stromal cells in intervertebral disc degeneration, prioritizing AP2S1 and CSTB
2. Frontiers in Immunology, 2026 -- Inflammatory protein mediators linking gut microbiota to degenerative lumbar spine disorders: cross-disease genetic evidence
3. Frontiers in Neurology, 2026 -- Integrating multi-omics and machine learning to explore the role of amino acid metabolism in intervertebral disk degeneration
4. AO Spine Clinical Practice Recommendations for Diagnosis and Management of Degenerative Cervical Myelopathy: Evidence Based Decision Making - A Review of Cutting Edge Recent Literature Related to Degenerative Cervical Myelopathy - PMC
5. Frontiers | Immune microenvironment in intervertebral disc degeneration: pathophysiology and therapeutic potential
6. Frontiers in Immunology — Swimming ameliorates intervertebral disc degeneration accompanied by Rpl23a downregulation and changes in its immune-inflammatory pathway
7. AO Spine Clinical Practice Recommendations for Diagnosis and Management of Degenerative Cervical Myelopathy: Evidence Based Decision Making - A Review of Cutting Edge Recent Literature Related to Degenerative Cervical Myelopathy - PMC
8. Frontiers | Immune microenvironment in intervertebral disc degeneration: pathophysiology and therapeutic potential
9. Mitochondrial DNA variation and intervertebral disc degeneration: a genotypic analysis in a South African cohort | Molecular Biology Reports | Springer Nature Link